E2L exhibiting at Cooper Hewitt, Smithsonian Design Museum
Monmouth company E2L is showcasing Welsh design and innovation in New York City as part of an exhibition at the Cooper Hewitt, Smithsonian Design Museum. The Welsh Government reports the two products by E2L have been designed to maintain mental engagement, self worth and dignity for people with dementia, helping them to recognise and retain … Continue reading E2L exhibiting at Cooper Hewitt, Smithsonian Design Museum
Jellagen receives ISO 13485:2016 certification
Cardiff-based marine biotechnology company Jellagen Pty Ltd has been certified to ISO 13485:2016, by leading certification body LRQA, for the manufacture of medical grade next generation collagen derived from jellyfish. ISO 13485:2016 specifies requirements for a quality management system where an organisation needs to demonstrate its ability to provide medical devices and related services that … Continue reading Jellagen receives ISO 13485:2016 certification
Creo Medical on track for 2019 commercial launch
Chepstow-headquartered medical products company Creo Medical is on track to launch its first commercial products in 2019. Creo produces devices for surgical endoscopy, with its Speedboat RS2 device using microwave and bi-polar radio frequency energy to perform surgical tasks. Insider Media reports, in interim results for six months to December 31st 2017, Creo said highlights … Continue reading Creo Medical on track for 2019 commercial launch
Formation Group invests £5m in Proton Partners
London-based construction business Formation Group has put £5m into radiation therapy company Proton Partners. Insider Media reports Formation Group has bought a 3.44% stake in the company, which also plans to open a proton beam therapy cancer centre in Abu Dhabi next year. Proton Partners International (PPI) is based in Newport with operational centres in … Continue reading Formation Group invests £5m in Proton Partners
Diurnal to raise £11m with placing
Specialist pharmaceutical company Diurnal is looking to raise £11m with a share offer to help launch products and fuel drug development. Insider Media reports, if the fundraising goes ahead, the proceeds will be used to launch the Cardiff-based company’s first product, Alkindi, into Europe as well as completing its US development. It will also be … Continue reading Diurnal to raise £11m with placing
Revenues pass £40m at EKF Diagnostics
Revenues at EKF Diagnostics have passed £40m, with the medical company confident of steady and sustainable growth. Insider Media reports Penarth-headquartered EKF recorded revenues of £41.6m for the full year to December 31st 2017, up from £38.6m in 2016 in part because of the fall in the value of sterling. Adjusted earnings (EBITDA) also increased, … Continue reading Revenues pass £40m at EKF Diagnostics
New funding for PulmonIR to tackle lung disease
Swansea University’s respiratory diagnostics spin-out company PulmonIR Ltd has won an Innovate UK Investment Accelerator grant worth £105,000. MediWales reports PulmonIR, who focus on detecting and monitoring lung disease, will use the funding to carry out further product development work before running extended clinical trials and securing regulatory approvals for its medical technology in the … Continue reading New funding for PulmonIR to tackle lung disease
Direct Healthcare acquires Transflo Cushion
Direct Healthcare has bought Transflo Cushion from Karomed in a deal advised on by HURST Corporate Finance. Direct Healthcare manufactures pressure care goods from its headquarters in Caerphilly. Insider Media reports the deal for Transflo Cushion is its third bolt on acquisition since private equity firm NorthEdge Capital backed the business in a management buyout … Continue reading Direct Healthcare acquires Transflo Cushion
Diurnal makes “significant steps”
Martin Whitaker, chief executive of Diurnal, has said his company has made significant steps towards becoming a revenue generating specialty pharma company focused on endocrinology. Insider Media reports in interim results for the six months to December 31st 2017, Cardiff headquartered Diurnal posted operational losses of £7.7m. Operational losses in the same period twelve months … Continue reading Diurnal makes “significant steps”
UK’s first proton therapy machine testing approved
Proton Partners International have announced that they and their partners Ion Beam Applications (IBA) Group have officially completed testing on the UK’s first high energy proton beam machine, the ProteusONE. The official completion and acceptance of testing took place at the Rutherford Cancer Centre in Newport. This is the fastest installation of a proton therapy … Continue reading UK’s first proton therapy machine testing approved
